Alpha crystalline form of strontium ranelate
US7745482B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 2008 |
| Grant date | Jun 29, 2010 |
| Priority date | — |
| Expiry date | Aug 12, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Alpha crystalline form of strontium ranelate of formula (I):characterised by its powder X-ray diffraction diagram and by a water content of from 22 to 24%.Medicinal products containing the same which are useful in the treatment of osteoporosis and arthrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.